View in a web browser.

FUJIFILM Cellular Dynamics
October 2020
Upcoming EventsTrendingArticles
CDI
Welcome
Upcoming Events
Cellular Dynamics

Webinar: Electrophysiological Phenotype Characterization of Human iPSC-Derived Neuronal Cell Lines by Means of High-Density Microelectrode Arrays
(Oct 15 | 11:00AM EDT).

Learn how HD-MEAs are used to characterize and compare human induced pluripotent stem cell (iPSC) derived dopaminergic and motor neurons, including isogenic neuronal lines modeling Parkinson's disease and amyotrophic lateral sclerosis in vitro.

REGISTER NOW >>

Cellular Dynamics

Webinar: A New Validated Human iPSC-Derived Cardiomyocyte Line for Diversification of Donor Responses in Drug Discovery and Safety Pharmacology Studies
(Oct 20 | 11:00AM EDT).

Learn about new footprint-free iCell® Cardiomyocytes2 11713 and their response to the CiPA-28 reference compounds, using a new protocol that enables quantitation of action potential morphology, as well as automated detection and classification of arrhythmias.

REGISTER NOW >>

Trending
Cellular Dynamics

Axxam and FUJIFILM Cellular Dynamics Announce Strategic Alliance to Deliver Integrated hiPSC Drug Discovery Solutions

Axxam S.p.A. and FUJIFILM Cellular Dynamics, Inc., announce a strategic alliance to improve the drug discovery process. The alliance will provide drug discovery researchers and scientists access to an integrated platform of hiPSC-based assays, through the application of the most advanced drug discovery technologies to enable target assessment, High-Throughput Screening (HTS), and High-Content Screening.

LEARN MORE >>


Articles
Cellular Dynamics

Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive Liver Cancer Based on a Balance of Risk and Benefit

See how researchers evaluated potency and safety of candidate T cell-based immunotherapeutics using human iPSC-derived iCell products.

Luo X, Cui H, Cai L, et al. Front Immunol. 2020;11:623. Published 2020 Apr 27. doi:10.3389/fimmu.2020.00623

SEE THE ARTICLE >>

Modeling Alpha-Synuclein Pathology in a Human Brain-Chip to Assess Blood-Brain Barrier Disruption in Parkinson's Disease

Discover how iCell DopaNeurons were incorporated into a human brain-on-chip model to study mechanisms of Parkinson's Disease progression and identify new therapeutic targets.

Iosif Pediaditakis, Konstantia R. Kodella, Dimitris V. Manatakis, Chris D. Hinojosa, Elias S. Manolakos, Lee L. Rubin, Geraldine A. Hamilton, Katia Karalis, bioRxiv 2020.07.22.207340 [preprint]

SEE THE ARTICLE >>

Electrophysiological Phenotype Characterization of Human iPSC-Derived Neuronal Cell Lines by Means of High-Density Microelectrode Arrays

Four different iCell neuronal cell lines, including both apparently healthy and disease model cells were characterized and compared using high-density microelectrode arrays. See the results.

Silvia Ronchi, Alessio Paolo Buccino, Gustavo Prack, Sreedhar Saseendran Kumar, Manuel Schröter, Michele Fiscella, Andreas Hierlemann bioRxiv 2020.09.02.271403 [preprint]

SEE THE ARTICLE >>

Follow UsFCDI TwitterFCDI LinkedInFCDI FacebookFCDI Youtube